These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3289183

  • 1. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA, Svendsen V, Rohr N, Hansen BL, Elbirk A, Foged N, Køhler F.
    Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring immunosuppression following renal transplantation.
    Giorgi JV, Cosimi AB, Colvin RB, Goldstein G, Delmonico FL, Russell PS.
    Diagn Immunol; 1983 Jun; 1(3):174-8. PubMed ID: 6388969
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct 10; 28(724):97-8. PubMed ID: 3531791
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of refractory acute rejection after renal transplantation with lymphogloline].
    Yu LX, Bai XW, Wang JY.
    Zhonghua Wai Ke Za Zhi; 1994 Jun 10; 32(6):348-50. PubMed ID: 7842959
    [Abstract] [Full Text] [Related]

  • 5. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
    Goldstein G, Norman DJ, Shield CF, Kreis H, Burdick J, Flye MW, Rivolta E, Starzl T, Monaco A.
    Prog Clin Biol Res; 1986 Jun 10; 224():239-49. PubMed ID: 3540993
    [No Abstract] [Full Text] [Related]

  • 6. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A, Goldstein G, Barnes L.
    Transplant Proc; 1987 Apr 10; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
    Alamartine E, Bellakoul R, Berthoux F.
    Transplant Proc; 1994 Feb 10; 26(1):273-4. PubMed ID: 8108975
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K, Munn SR, Sterioff S.
    Transplant Proc; 1996 Jun 10; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract] [Full Text] [Related]

  • 11. Definition, diagnosis, and treatment of acute kidney rejection--the first 30 days.
    Howard RJ.
    Transplant Proc; 1986 Apr 10; 18(2 Suppl 1):92-103. PubMed ID: 2421468
    [No Abstract] [Full Text] [Related]

  • 12. Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection.
    Ippoliti G, Fronterrè A.
    Transplant Proc; 1989 Feb 10; 21(1 Pt 3):3133-4. PubMed ID: 2523173
    [No Abstract] [Full Text] [Related]

  • 13. [Use of Orthoclone OKT3 in salvage treatment of primary acute renal allograft rejection resistant to steroids and antilymphocyte globulins].
    Guérin C, Daoud M, Paysant B, Sabatier JC, Berthoux P, Berthoux F.
    Nephrologie; 1988 Feb 10; 9(6):282-3. PubMed ID: 3070430
    [No Abstract] [Full Text] [Related]

  • 14. Immunosuppression in cardiac transplantation.
    Rose EA, Addonizio LJ.
    Bibl Cardiol; 1988 Feb 10; (43):1-9. PubMed ID: 3067706
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation.
    Wollenek G, Laufer G, Laczkovics A, Buxbaum P, Kober I.
    Transplant Proc; 1989 Feb 10; 21(1 Pt 3):2499-501. PubMed ID: 2495642
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP, Brown EA, Woodrow DF, Phillips ME, Gower PE, Mee AD.
    Transplantation; 1991 Oct 10; 52(4):746-9. PubMed ID: 1926361
    [No Abstract] [Full Text] [Related]

  • 18. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
    Bach JF, Dardenne M, Chatenoud L.
    Transplant Proc; 1982 Sep 10; 14(3):509-12. PubMed ID: 6758237
    [No Abstract] [Full Text] [Related]

  • 19. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP.
    Nephrol Dial Transplant; 1997 Sep 10; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract] [Full Text] [Related]

  • 20. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct 10; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.